A team of researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk have developed a new hormone combination for the future treatment of type 2 diabetes. The scientists have combined ...
Aug 26, 2022
0
129
California Governor Gavin Newsom announced Thursday that the state will spend $100 million to produce its own insulin.
Jul 8, 2022
1
4
In what is believed to be the first study of its kind, new UVA Health research reveals that a factory-calibrated continuous glucose monitor (CGM) may be sufficiently accurate for use by people on dialysis, a group often plagued ...
Jun 29, 2022
0
10
New research from 10 countries presented at this year's European Congress of Obesity (ECO) shows that nearly one quarter of adolescents living with obesity (ALwO) (24%) do not know they have obesity. However, most ALwO surveyed ...
May 5, 2022
0
6
A survey of adults with obesity from six Western European countries highlights the struggle people with obesity endure trying to lose weight, and sheds new light on what works and what doesn't when it comes to losing weight.
May 4, 2022
0
29
An estimated 25 percent of people older than 65 have type 2 diabetes, a condition in which the body cannot produce enough insulin to effectively manage blood sugar. Insulin plays an important role in the brain, and people ...
Apr 29, 2022
1
111
Rates of atrial fibrillation (AF) recurrence following ablation increase incrementally according to body mass index, both in short- and long-term follow-up, according to a study presented at the annual meeting of the European ...
Apr 5, 2022
0
26
A common food source has been converted into a biomanufacturing platform that offers a way to rapidly produce mass quantities of biologic drugs for common diseases that currently lack effective treatments. Researchers at ...
Mar 24, 2022
0
27
Acute kidney injury (AKI) is a common complication of COVID-19 and is associated with a higher risk of death. A new study published in CJASN has examined the use of palliative care in patients with COVID-19 and AKI.
Feb 24, 2022
0
4
(HealthDay)—Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous ...
Jan 21, 2022
0
50
